| 产品描述: | EMI48, the derivative of EMI1, displays greater potency toward mutant EGFR than EMI1. EMI48 inhibits EGFR triple mutants. |
| 靶点: |
EGFRL858R/T790M/C797S;EGFRdel19 T790M C797S |
| 体内研究: |
EMI48 inhibits EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S. EMI48 can be used in the research of mutant EGFR-associated, drug-resistant non-small-cell lung cancer (NSCLC). |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.87 ml |
14.351 ml |
28.703 ml |
| 5 mM |
0.574 ml |
2.87 ml |
5.741 ml |
| 10 mM |
0.287 ml |
1.435 ml |
2.87 ml |
| 50 mM |
0.057 ml |
0.287 ml |
0.574 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |